TREATMENT OF KAPOSIS-SARCOMA IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME WITH AN ALTERNATING VINCRISTINE-VINBLASTINE REGIMEN
- 1 September 1986
- journal article
- research article
- Vol. 70 (9) , 1121-1122
Abstract
Twenty-four patients with acquired immunodeficiency syndrome and Kaposi''s sarcoma (KS) were treated with a regimen alternating vincristine with vinblastine on a weekly basis. Objective responses to this regimen were observed in nine patients (45%), and seven (35%) had stabilization of progressive KS. Few toxic effects were observed. Alternating vincristine-vinblastine therapy is well-tolerated and effective palliative treatment for KS in acquired immunodeficiency syndrome.This publication has 3 references indexed in Scilit:
- Vinblastine Therapy for Kaposi's Sarcoma in the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1985
- Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parametersThe American Journal of Medicine, 1985
- Treatment of Kaposi's Sarcoma and Thrombocytopenia with Vincristine in Patients with the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1985